AMPICILLIN CAPSULES — Class III drug recall D-1350-2015
Terminated recall by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, reported 2015-08-26. Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
| Recall number | D-1350-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, Huntsville, AL, United States |
| Recall initiated | 2015-08-13 |
| Classified | 2015-08-20 |
| Reported by FDA | 2015-08-26 |
| Terminated | 2015-08-21 |
| Quantity | 360 bottles |
| Reason classes | labeling, unapproved product |
| NDC | 67253-0180-50 |
| Lot numbers | 04/18, 52217 |
Product
AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50
Reason for recall
Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1350-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.